AI-Powered Robotic "Multiplex" Drug Discovery

Ximyx Labs is pioneering AI-Powered, Robotic "Multiplex" Drug Discovery Contract Research Organization (CRO) to support a variety of therapeutic appro...

Accelerated Target Discovery
Comprehensive Service Offerings
  • Name: AI-Powered Robotic "Multiplex" Drug Discovery
  • Category: drug-discovery

About AI-Powered Robotic "Multiplex" Drug Discovery

Ximyx Labs is pioneering AI-Powered, Robotic "Multiplex" Drug Discovery Contract Research Organization (CRO) to support a variety of therapeutic approaches including Biologics Therapeutics, Genomics and Proteomics, Microbiome Drug Discovery, CAR-T Cell Therapy, and RNA-based Therapeutics.

Accelerated Target Discovery

Accelerated Target Discovery

Our robotic access accelerates large-scale experiments, significantly speeding up the target discovery process such as:

  • Discovery of new therapeutic targets and biomarkers
  • Repurposing existing drugs for other diseases
  • Identification of drug combinations and synergies for optimized treatment
  • Insights into cell biology
  • Early development of novel biologically active compounds for human disease treatment

Comprehensive Service Offerings

At Ximyx Labs we offer a comprehensive range of service offerings to our clients, including:

Access to Biological and Chemical Libraries: Access to a diverse array of biological and chemical libraries.

Specialized Applications and Pilot Validations: We offer support for specialized applications and pilot experiments that leverage automation, allowing researchers to explore innovative approaches in their work.

Customized AI Platform: Working with our partner Ailynix, to develop customized AI-Driven Drug Discovery platforms.

Comprehensive Service Offerings